Evaluation of Vapor Containment Efficacies of Air-Cleaning CSTDs and of Regular Syringes Using NIOSH Hazardous Drug Surrogates

Grants and Contracts Details

StatusFinished
Effective start/end date1/15/215/31/21

Funding

  • Equashield LLC: $7,805.00